TAMMY HARGETT: Open Payments
NPI 1720154842 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 36 payments from 13 companies in 2025. Trend: 2023 $732 · 2024 $799 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $142 |
| Lilly USA, LLC | 7 | $110 |
| ABBVIE INC. | 6 | $102 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Biogen, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
Products named: NURTEC ODT, MOUNJARO, Auvelity, PREVNAR 20, SHINGRIX, QULIPTA, JARDIANCE, UBRELVY.
Industry payments across IN — which companies pay providers there.
